The future of the global lactoferrin and lactoperoxidase market looks promising with opportunities in the infant formula, pharmaceutical, food & beverage, and sport nutrition markets.
- Within the product type category, lactoferrin is expected to witness higher growth over the forecast period due to lactoferrin has multiple applications in pharmaceuticals as well as nutraceuticals.
- Within the application category, infant formula is expected to witness the highest growth over the forecast period due to demand for infant formula with enhanced immunity is increasing.
- In terms of regions, APAC is expected to witness the highest growth over the forecast period due to increased birth rates, there is enhanced awareness for the proper nutrition of infants and children.
Emerging Trends in Lactoferrin and Lactoperoxidase Market
Lactoferrin and lactoperoxidase are growing markets for multifunctional ingredients for different applications within the dairy, oral care and supplements industries, and for infant feeding. Between 2025 and 2027, products within these markets are expected to be more efficacious, leaner and safer. Among other factors, improvement in processing economics and better manufacturing approaches will allow supplier to serve regional markets. According to Lucintel, regulation and innovation will differentiate suppliers.- Sustainability: From 2025 on, improved fractionation of milk and whey will allow dairy processors to recover lactoferrin from previously unrecoverable streams. If this technology becomes widespread, processors will be able to reduce the environmental footprint of their operations and improve resource use efficiency.
- Functional Products: From 2025, the use of lactoferrin to support gut health and barrier functions, as well as other modulate other applications in the immune system, will gain commercial support. The use of lactoferrin in combination with other ingredients, i.e. minerals and probiotics, to support oral health will gain commercial support in the aforementioned timeframe.
- Premiumization: Looking ahead to 2025, the infant nutrition market will continue to grow and segmented products will differentiate based on the level of lactoferrin included in the formula. In addition, purity and bioactivity will be important characteristics for products differentiating themselves from the competition.
- Digital Manufacturing: The facilities of the future will integrate laboratory and production systems to enable real-time monitoring and control of process. Predictive quality systems will allow control of process and significantly reduce variability. The integration of laboratory and production systems will help qualify products to multinational food and pharmaceutical companies.
- Diversification: By 2027, customers will qualify multiple suppliers based on geography. As a result, both North American and European companies will increase the number of processing facilities. Continuous supply of raw material of the required quality will remain a major challenge for companies.
Recent Developments in the Lactoferrin and Lactoperoxidase Market
Lactoferrin and lactoperoxidase are expected to have greater market potential in the next few years in the areas of infant and child nutrition, dietary supplements and food, and animal nutrition. The focus of marketing activity will shift during this period from the supply of raw materials to clinical studies and the introduction of products in various geographical regions. It is expected that the market will be increasingly competitive. This will be due to the increasing number of suppliers, and branded companies operating in the nutrition market to offer products containing different protein sources.- Capacity Expansion: Fonterra has announced further investments to increase supply of lactoferrin in 2025, and beyond. It is expected that supply will increase to the extent that shortages in the market will be resolved and lactoferrin will be used more broadly in medical and nutritional products.
- Portfolio Launches: In 2025, Friesland Campina Ingredients, announced the launch of a product line based on lactoferrin for use in nutrition products for consumers of all ages. With the entry of this company into this market, it is expected that more aggressive pricing policies will be implemented by competitors for lactoferrin-based products.
- Regulatory Approval: In 2025 the Chinese government made further amendments to its rules concerning the registration of infant formulas. This created increased barriers to entry into the Chinese market for infant formula products.
- Clinical Partnerships: Suppliers of lactoferrin ingredients stepped up their investment in university and hospital-based research in 2025 to explore its potential in the gut and other areas (October 2025). Current research is largely focused on the prevention and management of infection. More clinical research could support use in other areas and increase its market potential beyond supplements.
- Animal Health: The use of lactoperoxidase increased in the dairy industry in 2025, primarily in the field of calf and cow nutrition, as well as in swine and poultry farming (August 2025). This positively affected the outlook for the system and reduced its dependence on the infant nutrition market.
Strategic Growth Opportunities in the Lactoferrin and Lactoperoxidase Market
Clinical and market access restrictions for lactoferrin and lactoperoxidase are anticipated to loosen in 2024-2026. The launch of mass market protein-based nutritional products, the launch of products in the preventive health and wellness category, and the development of the clean-label food preservation industry are key trends that are expected to fuel the growth of the market during the forecast period. Lucintel expects that the market will grow beyond the infant formula category.- Clinical Nutrition: Hospital and recover clinician-supported enteral formulas have the potential to use lactoferrin to address malnutrition by helping to manage iron and other minerals. Evidence from dozens of clinical studies including a systematic review planned for 2025 may guide the development of safe and effective hospital nutrition formulas.
- Healthy Aging: Older adults are at risk of nutrition deficiencies. Lactoferrin may be used to improve iron and other minerals status. The United Nations, in January 2025, forecasted that by 2030, 1 out of 6 people will be 60 years and older.
- Oral Care: Lactoperoxidase is currently active in the dental professional care sector for the prevention and treatment of oral infections. Clinical trials of two formulations are set to complete in 2025. Given the focus on preventive dental care and the microbiome, lactoperoxidase is anticipated to be used more broadly in the dental care market.
- New Markets Lactoperoxidase's use can be further established in India, Southeast Asia, and the Gulf by localizing the formulation to adhere to regional regulations. In addition, recently increased dairy farm and cooperative infrastructure in India will improve the regional supply and distribution of dairy byproducts.
- Sustainability Use of lactoperoxidase in dairy will be further supported by the 2030 goal set by the EU for all product packaging to have a net zero impact on the environment, as manufacturers will support efforts to research and create lower impact products. Due to increasing demand for dairy byproducts to manufacture infant formula, suppliers that partner with regional regulators will gain first mover advantage.
Lactoferrin and Lactoperoxidase Market Drivers and Challenges
The market for lactoferrin and lactoperoxidase is driven by innovation, changing consumer and market conditions, and regulations. There is growing interest in the field of infant nutrition and other health and wellness categories (i.e. nutrition and diet supplements, pharmaceuticals, cosmetics, and animal nutrition). Further, industry advances have enabled commercialization in the abovementioned fields. Nonetheless, market expansion is limited by high costs of production and inequality in regulations and policies. Add kicked in enough barriers to make the market ripe for first-mover advantage and positive-sum competition. In the coming years, lucrative market opportunities, regulatory breakthroughs and successful health claims would allow companies to lock in competitive market position.The factors responsible for driving this market include:
- Growing Demand for Functional Nutrition: There is escalating interest in nutrition and other health-related products. As a result, in the coming years, the manufacture of nutrition and other health-related products, such as infant formulas, products for sports nutrition, and other health-related drinks and supplements, is expected to rise. In the coming years, the world population is anticipated to increase beyond 8 billion. Therefore, the potential consumer group for nutrition-related products will also increase. In the next 3 to 5 years, particularly in developed regions, there will be increased focus on preventive health. Age-related changes in the population will also stimulate interest in health and nutrition-related products. Suppliers of health-related products will need to be prepared to provide clinically proven and safe products. Convenience will also be an added advantage. Products in the form of beverages or supplements in capsules or sachets will be preferred.
- Increased Use in Infant Formula: Use of lactoferrin in formula for infants have been rising, on account of its role in the utilization of iron and development of the gut and immune system. Lactoferrin will also find increased use in other infant formulas, in view of the recommendations of the World Health Organization.
- Improvements in Technology: Further development of membrane filtration and chromatography technology has improved the purification and functionality of dairy ingredients. Further, the development of enzyme and protein stabilization and encapsulation technologies have improved the stability and shelf life of dairy ingredients. The milk and whey processing of 2025 involved multiple unit operations to enhance the value of dairy streams and to increase the number of fractions recovered. Within the next 3-5 years, similar developments are expected for the lactoperoxidase and other milk and whey stream fractions, improving the stability of lactoperoxidase for use in the oral care and other industries, and reducing the amount of milk and whey fractions utilized in the manufacture of products for humans and animals.
- Sustainability & Manufacturing: Like other industries, the dairy industry focuses on higher margins while reducing waste. In 2025, world-wide dairy processing created large quantities of by-product streams, e.g. whey. It is expected that within the next 3-5 years, biorefineries will be integrated with dairy processing to produce bioactive ingredients from dairy streams. Other improvements in manufacturing, e.g. more effective drying, use of better packaging, and reducing water use will also differentiate dairy processing and other industries in the future.
- Beyond Nutrition: Case studies show that the future of lactoferrin and lactoperoxidase may lie outside the nutritional realm. Of primary focus is research centred around their potential use cases in antimicrobial and antioxidant capacities. As mentioned in the 2020 report published by several global health organizations, including the World Health Organization, the increasing threat of antibiotic resistance will likely increase the need for products containing alternative, biologically-derived, constituents. This should encourage the further development of lactoferrin and lactoperoxidase. There is great potential for use in products ranging from oral and wound care to veterinary products and pharmaceuticals. The next few years will likely answer the viability of many of these use cases.
The challenges facing this market include:
- Expensive Production: Compared to traditional ingredients, lactoferrin and lactoperoxidase are expensive to produce and distribute. This is especially evident in the case of infant formula. In 2025, premium, recombined, infant formulas were sold at much higher prices than traditional formulas. The same trends are expected for other, higher-end, formulated-nutrition products in the next three to five years. Increased process automation and larger scale production facilities may allow for lower production costs in the same time frame.
- Barriers Due To Regulatory Environment and Evidence: Laws pertaining to safety, health claims, novel foods and pharmacology vary from one country to another. Throughout 2025, there was emphasis on the need to submit conclusive evidence on the safety and claims of functional ingredients. Consequently, industry was challenged to conduct clinical and toxicological studies. During the next 3 to 5 years, there will be differential and inconsistent approvals of functional food products, resulting in a company’s decision to avoid making any product claims. Development of well designed clinical studies will facilitate the transformation of biologically active ingredients to products that are legally permissible.
- Supply and Quality Constraints: Seasonal variation and health of the herd influence the quantity and quality of the milk. In 2025, various uncontrollable factors that include weather, energy costs and logistics continued to negatively impact the dairy industry.
List of Lactoferrin and Lactoperoxidase Market Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies lactoferrin and lactoperoxidase market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base.Some of the lactoferrin and lactoperoxidase market companies profiled in this report include:
- Arla Foods Ingredients Group P/S
- Fonterra Co-operative Group Limited
- Glanbia Nutritionals
- Tatua Co-operative Dairy Company Ltd.
- Milei GmbH
- Ingredia SA
- Synlait Milk Ltd.
- FrieslandCampina DOMO
- Agropur Cooperative
- Hilmar Cheese Company, Inc.
Lactoferrin and Lactoperoxidase Market by Segment
The study includes a forecast for the global lactoferrin and lactoperoxidase market by product type, source, function, application, and region.Product Type [Value ($B) from 2019 to 2035]:
- Lactoferrin
- Lactoperoxidase
Source [Value ($B) from 2019 to 2035]:
- Bovine Milk
- Human Milk
- Others
Function [Value ($B) from 2019 to 2035]:
- Antimicrobial
- Antioxidant
- Anti-inflammatory
- Others
Application [Value ($B) from 2019 to 2035]:
- Infant Formula
- Pharmaceuticals
- Food & Beverages
- Sports Nutrition
- Others
Region [Value ($B) from 2019 to 2035]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
Country Wise Outlook for the Lactoferrin and Lactoperoxidase Market
Lactoferrin and lactoperoxidase markets are changing due to growing regulation and domestic production of dairy derivates. It is expected that from 2025 to 2027, markets will be concerned about traceability and the compliance of the ingredients used in infant formulae. According to the latest study by Lucintel, the market will become more competitive. However, there will still be unfulfilled demand in different regions.- United States: To meet the requirements for infant formulae, in 2025 the FDA issued final guidelines to the industry on manufacturing practices. Suppliers of lactoferrin and other ingredients used in infant formulae enhanced their supply relationships. Above-mentioned tighter requirements will benefit suppliers of lactoferrin that have supplied domestic infant formulae manufacturers.
- China: China also revised its regulation on the registration of infant formulae to give a registration a 3-year validity period. SAMR also established more stringent requirements for the factories that produce the formulae. In 2025, a group of Chinese dairy companies, including Yili, announced that they will build a plant to produce nutrition products and invest in research on lactoferrin. Lactoferrin will be used in the high-end baby formulae.
- Germany: FrieslandCampina continued its construction work on its lactoferrin facility in the Netherlands. This facility is expected to be completed in 2025. In 2024, the company announced plans to spend €23 million on this project. Lactoferrin plays an important role in pharmaceutical and infant formula production. Therefore, this investment by FrieslandCampina should secure Europe’s supply of lactoferrin.
- India: Lactoferrin was permitted to be marketed as a nutraceutical and a food for specific health use by the Food Safety and Standards Authority of India (FSSAI). In the recent budget, the FSSAI outlined plans to strengthen the country’s dairy processing and marketing system to realize the dream of “Swasth Bharat”. With strong organized dairy systems, indigenous production of lactoferrin is possible.
- Japan: In 2025, Morinaga stated that it would continue its research on lactoferrin and other nutritional products. Given Japan’s commitment to clinical research, lactoferrin products produced in this region may satisfy consumer demands in the Asia Pacific region in the next 3-5 years.
Features of the Global Lactoferrin and Lactoperoxidase Market
- Market Size Estimates: lactoferrin and lactoperoxidase market size estimation in terms of value ($B).
- Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions.
- Segmentation Analysis: lactoferrin and lactoperoxidase market size by various segments, such as by product type, source, function, application, and region in terms of value ($B).
- Regional Analysis: lactoferrin and lactoperoxidase market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different product types, sources, functions, applications, and regions for the lactoferrin and lactoperoxidase market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the lactoferrin and lactoperoxidase market.- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers the following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the lactoferrin and lactoperoxidase market by product type (lactoferrin and lactoperoxidase), source (bovine milk, human milk, and others), function (antimicrobial, antioxidant, anti-inflammatory, and others), application (infant formula, pharmaceuticals, food & beverages, sports nutrition, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 8 years and what has its impact been on the industry?
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- Arla Foods Ingredients Group P/S
- Fonterra Co-operative Group Limited
- Glanbia Nutritionals
- Tatua Co-operative Dairy Company Ltd.
- Milei GmbH
- Ingredia SA
- Synlait Milk Ltd.
- FrieslandCampina DOMO
- Agropur Cooperative
- Hilmar Cheese Company, Inc.
Methodology
The analyst has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets/applications and served over 1,000 clients worldwide. Each study is a culmination of four months of full-time effort performed by the analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in the market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of professionals, who have analyzed and tracked the market over the years.
Extensive research and interviews are conducted in the supply chain of the market to estimate market share, market size, trends, drivers, challenges and forecasts.
Thus, the analyst compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. The analyst then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process.

LOADING...

